|
MFF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76060000023348E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8104099999916E-05 |
| Normal-vs-Stage2 |
1.503580E-03 |
| Normal-vs-Stage3 |
8.08649999961553E-07 |
| Normal-vs-Stage4 |
2.17200000000028E-05 |
| Stage1-vs-Stage2 |
7.297400E-01 |
| Stage1-vs-Stage3 |
2.673200E-01 |
| Stage1-vs-Stage4 |
6.044800E-01 |
| Stage2-vs-Stage3 |
7.459800E-01 |
| Stage2-vs-Stage4 |
9.621000E-01 |
| Stage3-vs-Stage4 |
7.317200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7510000005494E-07 |
| Normal-vs-AfricanAmerican |
2.551600E-02 |
| Normal-vs-Asian |
4.657800E-02 |
| Caucasian-vs-AfricanAmerican |
1.680400E-01 |
| Caucasian-vs-Asian |
1.224310E-02 |
| AfricanAmerican-vs-Asian |
6.468000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.444830E-04 |
| Normal-vs-Female |
7.06010000461887E-08 |
| Male-vs-Female |
1.914410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.13479999999766E-05 |
| Normal-vs-Age(41-60Yrs) |
4.74909999992335E-07 |
| Normal-vs-Age(61-80Yrs) |
1.65419E-05 |
| Normal-vs-Age(81-100Yrs) |
7.841900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.754600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.883400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.770400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.389400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.348800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.085000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.237600E-01 |
| Classical-VS-Follicular |
2.754200E-01 |
| Classical-VS-Other |
9.669600E-01 |
| Classical-VS-Normal |
2.01109999999893E-05 |
| Tall-VS-Follicular |
8.369400E-01 |
| Tall-VS-Other |
5.992200E-01 |
| Tall-VS-Normal |
3.401400E-04 |
| Follicular-VS-Other |
7.143200E-01 |
| Follicular-VS-Normal |
6.17929999999767E-05 |
| Other-VS-Normal |
9.689700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.78550000129852E-08 |
| Normal-vs-N1 |
3.2811000000299E-06 |
| N0-vs-N1 |
8.789000E-01 |
|
|
